References
- Rowley J.D. A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 1973; 243: 290–293
- Heisterkamp N., Stephenson J.R., Groffen J., Hansen P.F., de Klein A., Bartram C.R., Grosveld G. Localization of the c-abl oncogene adjacent to a translocation breakpoint in chronic myelocytic leukemia. Nature 1983; 306: 239–242
- Groffen J., Stephenson J.R., Heisterkamp N., de Klein A., Bartram C.R., Grosveld G. Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell 1984; 36: 93–99
- Heisterkamp N., Stam K., Groffen J., de Klein A., Grosveld G. Structural organization of the bcr gene and its role in the Ph translocation. Nature 1985; 315: 758–761
- Leibowitz D., Schaefer-Rego K., Popenoe D.W., Mears J.G., Bank A. Variable breakpoints on the Philadelphia chromosome in chronic myelogenous leukemia. Blood 1985; 66: 243–245
- Pangalis G.A. Contribution of Cytochemistry in Leukemia. Leukemias Human, A. Polliack. Martinus Nijhoff, Boston 1984; 3–14
- Canaani E., Steiner-Saltz D., Aghai E., Gale R.P., Bemebi A., Januszewicz E. Altered transcription of an oncogene in chronic myeloid leukaemia. Lancet 1984; 593–595
- Leibowitz D., Cubbon R., Bank A. Increased expression of a novel c-abl related RNA in K562 cells. Blood 1985; 65: 526–529
- Kloetzer W., Kurzrock R., Smith L., Talpaz M., Spiller M., Gutterman J., Arlinghaus R. The human cellular abl gene product in the chronic myelogenous leukemia cell line K562 has an associated tyrosine protein kinase activity. Virology 1985; 140: 230–238
- Ben-Neriah Y., Daley G.O., Mes Masson A.-M., Witte O.N., Baltimore D. The chronic myelogenous leukemia-specific p210 protein is the product of the bcr/abl hybrid gene. Science 1986; 233: 212–214
- Schaefer-Rego K., Dudek H., Popenoe D., Arlin Z., Mears J.G., Bank A., Leibowitz D. CML patients in blast crisis have breakpoints localized to a specific region of the BCR. Blood 1987; 70: 448–455
- Eisenberg A., Silver R., Soper L., Arlin Z., Coleman M., Bemhardt B., Benn P. The location of breakpoints within the breakpoint cluster region (bcr) of chromosome 22 in chronic myeloid leukemia. Leukemia 1988; 2: 642–647
- Shtalrid M., Talpaz M., Kurzrock R., Kantarjian H., Trujillo J., Gutterman J., Galina Y., Mark B. Analysis of breakpoints within the bcr gene and their correlation with clinical course of Philadelphia-positive chronic myelogenous leukemia. Blood 1988; 72: 485–490
- Jaubert J., Martiat P., Dowding C., Ifrah N., Goldman J.M. The position on the M-BCR breakpoint does not predict the duration of chronic phase or survival in chronic myeloid leukemia. Br. J. Haematol. 1990; 74: 30–35
- Birnie G.D., Mills K.I., Benn P. Does the site of the breakpoint on chromosome 22 influence the duration of the chronic phase in chronic myeloid leukemia?. Leukemia 1989; 3: 545–547
- Southern E.M. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 1975; 98: 503–517
- Popenoe D.W., Shaefer-Rego K., Mears J.G., Bank A., Leibowitz D. Frequent and extensive deletion during the 9,22 translocation in CML. Blood 1986; 68: 1123–1128
- Bartram C.R., de Klein A., Hagemeijer A., Carbonell F., Kleihauer E., Grosveld G. Additional c-abl/bcr rearrangements in a CML patients exhibiting two Ph1 chromosomes during blast crisis. Leukemia Res. 1986; 10: 221–225
- Shtivelman E., Gale R.P., Drearen O., Berrebi A., Zaizov R., Kubonishi I., Miyoshi I., Canaani E. Bcr-abl RNA in patients with chronic myelogenous leukemia. Blood 1987; 69: 971–973
- Morris S.W., Daniel L., Ahmed C.M.I., Elian A., Leibowitz D. Relationship of the bcr breakpoint to chronic phase duration, survival and blast crisis lineage in chronic myelogenous leukemia patients presenting in early chronic phase. Blood 1990; 75: 2035–2041
- Inokuchi K., Inoue T., Tojo A., Futaki M., Miyake K., Yamada T., Tanabe Y., Ohki I., Dan K., Ozawa K., Asano S., Nomura T. A possible correlation between the type of bcr-abl Hybrid messenger RNA and platelet count in Philadelphia-positive chronic myelogenous leukemia. Blood 1991; 78: 3125–3127
- Inokuchi K., Futaki M., Yamada T., Tanabe Y., Dan K., Shinoharo T., Kuriya S.I., Nomura T. The relationship between the site of breakpoints with the BCR gene and thrombopoiesis of Philadelphia-positive chronic myelocytic leukemia. Leukemia Res. 1991; 15: 1067–1073
- Opalka B., Wandl U.B., Kloke O., Beer U., Seeber S., Niederle N. No correlation between site of breakpoint in the BCR Gene and Platelet counts in Philadelphia chromosome-positive CML. Leukemia Rex 1992; 16: 937–939